ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Arcturus Therapeutics (ARCT) Stock: Buy, Sell, or Hold?
$8.65
-0.67 (-7.14%)
▼
5d:
-7.64%
30d:
-22.26%
90d:
+5.04%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (76%)
Quality Score
52/100
Position
OVERSOLD
30-Day Fair Range
$9.58 – $12.51
Position: OVERSOLD
Forward P/E & Valuation
-2.7x
Next 12M consensus est.
Wall Street Target
$23.80
+155.6% upside
Options IV & Volume
57th pct IV
HIGH volume confirmation
Support / Resistance
$8.62 / $11.93
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ARCT shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ARCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARCT is currently trading at $8.64, which is considered oversold relative to its 30-day fair value range of $9.58 to $12.51.
Technical Outlook: Technically, ARCT is in a strong uptrend. The price is currently testing key support at $8.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $23.80 (+155.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARCT is in a strong uptrend. The price is currently testing key support at $8.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $23.80 (+155.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.58 -
$12.51
Company Quality Score
52/100
(HOLD)
Options IV Signal
57th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
Trading Range & Key Levels
30-Day Trading Range
$9.58 -
$12.51
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.30
(15.0%)
Support Level
$8.62
Resistance Level
$11.93
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 57th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.1%)
- BULLISH: Trading 155.6% below Wall St target ($23.80)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.70
Wall Street Target
$23.80
(+155.6%)
Revenue Growth (YoY)
6.7%
Profit Margin
-285.9%
Share ARCT Analysis
Share this live ARCT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARCT)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment for $ARCT, with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:23 PM ET
Data refreshes hourly during market hours. Next update: 3:23 PM
Data refreshes hourly during market hours. Next update: 3:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARCT Research Pages
